EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
The EAHP EU Monitor is a weekly round up of news relevant to hospital pharmacy in Europe. 
You can subscribe to the EAHP EU Monitor here.
EAHP launch survey on medicines shortages impact on patient care
As part of its ongoing work to highlight the urgency of current problems hospitals are experiencing with medicines shortages, EAHP has launched a new survey to better understand the impacts shortages have in relation to care to the patient.
The short survey of seven questions seeks to find out whether hospital pharmacists consider the medicines shortage problem is getting worse or getting better, whether shortages have negative impacts on patient care, what hospital pharmacists believe are the principal causes of shortages and what they believe would be the most useful solutions to enact.
Hospital Pharmacists are asked to make responses by the end of January 2013.
Survey here
A previous EAHP survey, launched in September 2012, remains open for responses, and looks to understand the prevalence and nature of the shortage problem across Europe.
September 2012 Survey here
Commission publish action plan on “A digital future for healthcare”
The European Commission has unveiled an Action Plan “to address barriers to the full use of digital solutions in Europe's healthcare systems”.
The Commission believes that “while patients and health professionals are enthusiastically using telehealth solutions and millions of Europeans have downloaded smartphone apps to keep track of their health and wellbeing, digital healthcare has yet to reap its great potential to improve healthcare and generate efficiency savings.”
Therefore, in order to address this challenge, the Commission’s Action Plan aims to:
The Action Plan notes that despite the economic crisis, the global telemedicine market grew from $9.8 billion in 2010 to $11.6 billion in 2011, while the global mHealth market is set to grow to €17.5 billion a year by 2017.
The Commission also commits to issue a mHealth (Mobile Health) Green Paper by 2014 addressing quality and transparency issues.
The legal status of telemedicine is also a particular focus of an accompanying Staff Working Paper, which gives a legal overview of how current EU legislation applies to this area. It addresses such questions as:
More information here.
Short video here.
The European Medicines Agency is inviting persons with an interest in the publishing formats and rules of engagement for access to clinical trial data to express an interesting in joining 5 special advisory groups by Friday 21 December.
The call follows an earlier workshop held in November 2012 as the EMA prepares to enact a policy of proactive publication of clinical trial data. The groups are seen as a key means for the Agency to have developed dialogue with stakeholders in 5 key areas:
1. Protecting patient confidentiality
2. Clinical-trial-data formats
3. Rules of engagement (conditions stakeholders may need to meet in order to download data)
4. Good analysis practice (EMA may recommend guidelines in this area to data requestors)
5. Legal aspects (understanding when data may be commercially sensitive)
Please email richard [dot] price [at] eahp [dot] eu if you are a hospital pharmacist with an interest and experience in relation to clinical trial activity, and would like to be considered as an EAHP nominee to any of the 5 advisory groups.
Most of the advisory group activity will be conducted by virtual methods (e.g. email and teleconference).
The bulk of the advisory group activity is intended to be conducted between January and April 2013.
More information about the call for participation here.
Report of the November 2012 Clinical Trial Data workshop here.
In the latest edition of the EJHP, new Editor-in-Chief Philip Wiffin writes on the evolution and use of the Evidence-based Medicine (EBM) concept.
This article looks at the background and definitions of EBM together with an outline of the tools that can support EBM in practice. In particular the role of systematic reviews and the utility of forest plots, L'Abbe plots and numbers needed to treat are presented.
See the full edition here.
